With sharp declines in the cost of whole genome sequencing, the day of accurately deciphering disease risk based on an individual's genome may seem at hand. But a study involving data of thousands of identical twins by Johns Hopkins investigators finds that genomic fortune-telling fails to provide informative guidance to most people about their risk for most common diseases, and warns against complacency born of negative genome test results.
- Whole genome sequencing not informative for all, Johns Hopkins study showsMon, 2 Apr 2012, 18:34:08 EDT
- Complete Genomics publishes in Science on low-cost sequencing of 3 human genomesThu, 5 Nov 2009, 15:22:31 EST
- Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencingThu, 18 Feb 2010, 14:34:22 EST
- DNA of uncultured organisms sequenced using novel single-cell approachWed, 22 Apr 2009, 12:08:47 EDT
- Stanford study first to analyze individual's genome for risk of diseases, responses to treatmentThu, 29 Apr 2010, 19:16:41 EDT